BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 23645323)

  • 1. Long-term control of ambulatory hypertension in children: improving with time but still not achieving new blood pressure goals.
    Seeman T; Gilík J
    Am J Hypertens; 2013 Jul; 26(7):939-45. PubMed ID: 23645323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Control of hypertension in treated children and its association with target organ damage.
    Seeman T; Dostálek L; Gilík J
    Am J Hypertens; 2012 Mar; 25(3):389-95. PubMed ID: 22089110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
    Seeman T; Dusek J; Vondrák K; Flögelová H; Geier P; Janda J
    Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved control of hypertension in children after renal transplantation: results of a two-yr interventional trial.
    Seeman T; Simková E; Kreisinger J; Vondrák K; Dusek J; Gilík J; Dvorák P; Janda J
    Pediatr Transplant; 2007 Aug; 11(5):491-7. PubMed ID: 17631016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronotherapy with valsartan/hydrochlorothiazide combination in essential hypertension: improved sleep-time blood pressure control with bedtime dosing.
    Hermida RC; Ayala DE; Mojón A; Fontao MJ; Fernández JR
    Chronobiol Int; 2011 Aug; 28(7):601-10. PubMed ID: 21823969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Continuous ambulatory measurement of blood pressure in children--personal experience].
    Peco-Antić A; Pejcić I; Stojanov V; Kostić M; Kruscić D; Jovanović O; Mancić J
    Srp Arh Celok Lek; 1997; 125(7-8):197-202. PubMed ID: 9304231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of nighttime and daytime interval definition on blood pressure and dipping in patients referred for ambulatory blood pressure measurement].
    Muller ME; Bochud M; Pruijm M; Iglesias K; Burnier M; Wuerzner G
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):193-7. PubMed ID: 22683138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABPM vs office blood pressure to define blood pressure control in treated hypertensive paediatric renal transplant recipients.
    Ferraris JR; Ghezzi L; Waisman G; Krmar RT
    Pediatr Transplant; 2007 Feb; 11(1):24-30. PubMed ID: 17239120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of hypertension in children after renal transplantation.
    Seeman T; Simková E; Kreisinger J; Vondrák K; Dusek J; Gilík J; Feber J; Dvorák P; Janda J
    Pediatr Transplant; 2006 May; 10(3):316-22. PubMed ID: 16677355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regression of left-ventricular hypertrophy in children and adolescents with hypertension during ramipril monotherapy.
    Seeman T; Gilík J; Vondrák K; Simková E; Flögelová H; Hladíková M; Janda J
    Am J Hypertens; 2007 Sep; 20(9):990-6. PubMed ID: 17765141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nocturnal blood pressure non-dipping is not associated with increased left ventricular mass index in hypertensive children without end-stage renal failure.
    Seeman T; Hradský O; Gilík J
    Eur J Pediatr; 2016 Aug; 175(8):1091-7. PubMed ID: 27344339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2010 Sep; 27(8):1629-51. PubMed ID: 20854139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression to hypertension in non-hypertensive children following renal transplantation.
    Sinha MD; Gilg JA; Kerecuk L; Reid CJ;
    Nephrol Dial Transplant; 2012 Jul; 27(7):2990-6. PubMed ID: 22287656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.